{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:40:38Z","timestamp":1794109238782,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601108"],"award-info":[{"award-number":["81601108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Shandong Province of China","award":["ZR2016HQ14"],"award-info":[{"award-number":["ZR2016HQ14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05377-4","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:10:45Z","timestamp":1762553445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potential Therapeutic Effects of Astragaloside IV in Parkinson\u2019s Disease Models via Modulation of \u03b1-syn-\u03b3H2AX-STING-IFN-I Axis"],"prefix":"10.1007","volume":"63","author":[{"given":"Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"3","key":"5377_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G et al (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14(3):176","journal-title":"Cell Death Dis"},{"key":"5377_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00702-010-0428-1","volume":"117","author":"L Qian","year":"2010","unstructured":"Qian L, Flood PM, Hong J-S (2010) Neuroinflammation is a key player in Parkinson\u2019s disease and a prime target for therapy. J Neural Transm 117:971\u2013979","journal-title":"J Neural Transm"},{"key":"5377_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00370","volume":"10","author":"G Zhang","year":"2018","unstructured":"Zhang G, Xia Y, Wan F et al (2018) New perspectives on roles of alpha-synuclein in Parkinson\u2019s disease. Front Aging Neurosci 10:370","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"5377_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126517","volume":"22","author":"A Cardinale","year":"2021","unstructured":"Cardinale A, Calabrese V, de Iure A et al (2021) Alpha-synuclein as a prominent actor in the inflammatory synaptopathy of Parkinson\u2019s disease. Int J Mol Sci 22(12):6517","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5377_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40035-024-00401-4","volume":"13","author":"E Leandrou","year":"2024","unstructured":"Leandrou E, Chalatsa I, Anagnostou D et al (2024) \u03b1-Synuclein oligomers potentiate neuroinflammatory NF-\u03baB activity and induce Cav3. 2 calcium signaling in astrocytes. Transl Neurodegener 13(1):11","journal-title":"Transl Neurodegener"},{"issue":"4","key":"5377_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med 38(4):333\u2013347","journal-title":"Exp Mol Med"},{"issue":"3","key":"5377_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"MG Tansey","year":"2019","unstructured":"Tansey MG, Romero-Ramos M (2019) Immune system responses in Parkinson\u2019s disease: early and dynamic. Eur J Neurosci 49(3):364\u2013383","journal-title":"Eur J Neurosci"},{"key":"5377_CR8","doi-asserted-by":"publisher","first-page":"105094","DOI":"10.1016\/j.neuint.2021.105094","volume":"148","author":"T Zheng","year":"2021","unstructured":"Zheng T, Zhang Z (2021) Activated microglia facilitate the transmission of \u03b1-synuclein in Parkinson\u2019s disease. Neurochem Int 148:105094","journal-title":"Neurochem Int"},{"issue":"3","key":"5377_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00011-022-01676-x","volume":"72","author":"Q-K Lv","year":"2023","unstructured":"Lv Q-K, Tao K-X, Wang X-B et al (2023) Role of \u03b1-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson\u2019s disease. Inflamm Res 72(3):443\u2013462","journal-title":"Inflamm Res"},{"issue":"9","key":"5377_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S et al (2021) The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21(9):548\u2013569","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"5377_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","volume":"20","author":"M Motwani","year":"2019","unstructured":"Motwani M, Pesiridis S, Fitzgerald KA (2019) DNA sensing by the cGAS\u2013STING pathway in health and disease. Nat Rev Genet 20(11):657\u2013674","journal-title":"Nat Rev Genet"},{"issue":"5","key":"5377_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC (2005) Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 5(5):375\u2013386","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"5377_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tins.2020.10.008","volume":"44","author":"BD Paul","year":"2021","unstructured":"Paul BD, Snyder SH, Bohr VA (2021) Signaling by cGAS\u2013STING in neurodegeneration, neuroinflammation, and aging. Trends Neurosci 44(2):83\u201396","journal-title":"Trends Neurosci"},{"key":"5377_CR14","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","volume":"74","author":"V Tapias","year":"2017","unstructured":"Tapias V, Hu X, Luk KC et al (2017) Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production. Cell Mol Life Sci 74:2851\u20132874","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"5377_CR15","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s12276-022-00895-w","volume":"54","author":"T-K Kim","year":"2022","unstructured":"Kim T-K, Bae E-J, Jung BC et al (2022) Inflammation promotes synucleinopathy propagation. Exp Mol Med 54(12):2148\u20132161","journal-title":"Exp Mol Med"},{"key":"5377_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.apha.2019.08.002","volume":"87","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wu C, Gao L et al (2020) Astragaloside IV derived from Astragalus membranaceus: a research review on the pharmacological effects. Adv Pharmacol 87:89\u2013112","journal-title":"Adv Pharmacol"},{"issue":"1","key":"5377_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12035-023-03566-7","volume":"61","author":"M Wang","year":"2024","unstructured":"Wang M, Sun F, Han X et al (2024) Astragaloside IV inhibits rotenone-induced \u03b1-syn presentation and the CD4 T-cell immune response. Mol Neurobiol 61(1):252\u2013265","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5377_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","volume":"75","author":"B Channer","year":"2023","unstructured":"Channer B, Matt SM, Nickoloff-Bybel EA et al (2023) Dopamine, immunity, and disease. Pharmacol Rev 75(1):62\u2013158","journal-title":"Pharmacol Rev"},{"key":"5377_CR19","doi-asserted-by":"publisher","first-page":"105651","DOI":"10.1016\/j.intimp.2019.05.036","volume":"75","author":"C Yang","year":"2019","unstructured":"Yang C, Mo Y, Xu E et al (2019) Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson\u2019s disease mouse model. Int Immunopharmacol 75:105651","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"5377_CR20","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41418-021-00767-2","volume":"28","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang B, Zhang C et al (2021) The DJ1-Nrf2-STING axis mediates the neuroprotective effects of withaferin A in Parkinson\u2019s disease. Cell Death Differ 28(8):2517\u20132535","journal-title":"Cell Death Differ"},{"issue":"1","key":"5377_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12974-024-03072-0","volume":"21","author":"M Wang","year":"2024","unstructured":"Wang M, Tian T, Zhou H et al (2024) Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson\u2019s disease through Mfn2-cGAS signaling. J Neuroinflammation 21(1):81","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5377_CR22","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP et al (2020) Microglia clear neuron-released \u00ce\u0105-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun 11(1):1386","journal-title":"Nat Commun"},{"issue":"5","key":"5377_CR23","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.neuint.2013.02.004","volume":"62","author":"A Wilkaniec","year":"2013","unstructured":"Wilkaniec A, Strosznajder JB, Adamczyk A (2013) Toxicity of extracellular secreted alpha-synuclein: its role in nitrosative stress and neurodegeneration. Neurochem Int 62(5):776\u2013783","journal-title":"Neurochem Int"},{"issue":"3","key":"5377_CR24","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1046\/j.1471-4159.1995.65031411.x","volume":"65","author":"J Zhang","year":"1995","unstructured":"Zhang J, Pieper A, Snyder SH (1995) Poly (ADP-ribose) synthetase activation: an early indicator of neurotoxic DNA damage. J Neurochem 65(3):1411\u20131414","journal-title":"J Neurochem"},{"issue":"1","key":"5377_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ni.2491","volume":"14","author":"DL Burdette","year":"2013","unstructured":"Burdette DL, Vance RE (2013) STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol 14(1):19\u201326","journal-title":"Nat Immunol"},{"issue":"6","key":"5377_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuro.2011.05.012","volume":"32","author":"C-J Choong","year":"2011","unstructured":"Choong C-J, Say Y-H (2011) Neuroprotection of \u03b1-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson\u2019s disease mutations A30P, A53T and E46K. Neurotoxicology 32(6):857\u2013863","journal-title":"Neurotoxicology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05377-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05377-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05377-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:10:46Z","timestamp":1762553446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05377-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5377"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05377-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"11"}}